The Why of Weight Loss Plateaus Weight loss plateaus are common and frustrating phases where the body resists further weight loss despite continued efforts in dieting and exercise. Understanding this phenomenon is crucial for effectively managing and overcoming these plateaus. Several physiological, metabolic, and hormonal factors contribute to the occurrence of weight loss plateaus. Adaptive…
Finding the Balance Maintaining muscle mass during weight loss using medications like GLP1 or GIP/GLP1 RA such as semaglutide (Ozempic) and tirzepatide (Mounjaro) can be tricky but not impossible. These medications often induce a reduction in “food noise,” produce a strong satiety signal early on in a meal, which curbs the desire to eat excessively….
Metabolic Syndrome and Severity Score (MSSS) Calculator. Understand your risk for disease.
It’s Not Just About Aesthetics How to get rid of belly fat. It’s the hot topic among body and health-conscious individuals that has reigned supreme for a millennium and showing no signs of exhaustion. Admittedly, excess belly fat, also known as abdominal obesity, can be unsightly, but the real issue is deeper than looking our…
GLP-1 on the Brain? GLP-1 is well-known for its gut effects, such as slowing gastric emptying and reducing hunger, which promotes weight loss. However, GLP-1 is also produced in the brain and plays a crucial role in neuroprotection by activating GLP-1 receptor pathways. This enhances learning and memory in the hippocampus, promotes neurogenesis (brain cell…
Carrying excess weight is a risk factor for prediabetes which is a growing health problem. Having prediabetes means your blood glucose (sugar) levels are higher than normal—but not high enough to be diagnosed as diabetes. Prediabetes can lead to heart disease, stroke, and type 2 diabetes, the most common form of diabetes. Prediabetes is a…
About “Ozempic Face” The GLP-1 agonists Ozempic or Wegovy, which contain Semaglutide aids in weight loss by affecting digestion and suppressing appetite through gut and brain chemical modulation. These drugs are popular for effectively treating type 2 diabetes and obesity and while they improve cardiometabolic profiles, diabetes, and metabolic syndrome, they are not without risks…
Tirzepatide is the active ingredient in Mounjaro, a medication by Eli Lilly. It is a dual agonist of the GLP-1 and GIP receptors, which control appetite. It not only suppresses appetite, but it also improves satiety, delays stomach emptying, improves insulin sensitivity, and benefits the heart and cholesterol levels. Indications and Mechanism of Action Tirzepatide…
